Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) reported earnings for its first quarter that Increased, from last year
The company's earnings came in at RMB865.99 million, or RMB0.7387 per share. This compares with RMB516.83 million, or RMB0.4396 per share, last year.
The company's revenue for the period fell 17.4% to RMB514.09 million from RMB622.62 million last year.
Jilin Aodong Pharmaceutical Group Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB865.99 Mln. vs. RMB516.83 Mln. last year.-EPS: RMB0.7387 vs. RMB0.4396 last year.-Revenue: RMB514.09 Mln vs. RMB622.62 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.